Peter Mercado
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
- Oncology 5
- Cancer Cells and Metastasis 3
-
- Protein Degradation and Inhibitors 1
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Lionel Feigenbaum (1 shared paper)Philippe Galéra (1 shared paper)Guangping Sun (1 shared paper)S. Rhiannon Jenkinson (1 shared paper)Xiaolong Liu (1 shared paper)Magdalini Kypriotou (1 shared paper)Rémy Bosselut (1 shared paper)David Epstein (5 shared papers)
- Journals
- Clinical & Experimental Metastasis (2 papers)Clinical Cancer Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)Cells Tissues Organs (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesAustriaFrance
In The Last Decade
Peter Mercado
8 papers receiving 666 citations
Peers
Comparison fields: 5 of 75
- Immunology 240
- Oncology 208
- Cancer Research 114
- Immunology and Allergy 29
- Molecular Biology 254
Countries citing papers authored by Peter Mercado
This map shows the geographic impact of Peter Mercado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mercado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mercado more than expected).
Fields of papers citing papers by Peter Mercado
This network shows the impact of papers produced by Peter Mercado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mercado. The network helps show where Peter Mercado may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Mercado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 228 | |
| 2 | 2010 | 179 | |
| 3 | 2004 | 106 | |
| 4 | 2011 | 53 | |
| 5 | 2017 | 43 | |
| 6 | The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy. | 2012 | 40 |
| 7 | 2010 | 24 | |
| 8 | 2012 | 1 |
About Peter Mercado
Peter Mercado is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 8 papers that have together received 674 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Liver physiology and pathology (2 papers), Lung Cancer Treatments and Mutations (2 papers), Blood properties and coagulation (1 paper), Cancer Genomics and Diagnostics (1 paper), Immunotherapy and Immune Responses (1 paper), Protein Degradation and Inhibitors (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Immunology (240 citations), Oncology (208 citations), Cancer Research (114 citations), Immunology and Allergy (29 citations) and Molecular Biology (254 citations). Peter Mercado has collaborated with scholars based in United States, Austria and France. Frequent co-authors include Lionel Feigenbaum, Philippe Galéra, Guangping Sun, S. Rhiannon Jenkinson, Xiaolong Liu, Magdalini Kypriotou, Rémy Bosselut, David Epstein, Gretchen Argast and Stuart Thomson. Their work appears in journals such as Clinical & Experimental Metastasis, Clinical Cancer Research, Proceedings of the National Academy of Sciences, Cells Tissues Organs and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.